149 related articles for article (PubMed ID: 18081322)
1. Chemical interplay in the mechanism of partial agonist activation in alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors.
Mankiewicz KA; Rambhadran A; Wathen L; Jayaraman V
Biochemistry; 2008 Jan; 47(1):398-404. PubMed ID: 18081322
[TBL] [Abstract][Full Text] [Related]
2. Role of the chemical interactions of the agonist in controlling alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor activation.
Mankiewicz KA; Rambhadran A; Du M; Ramanoudjame G; Jayaraman V
Biochemistry; 2007 Feb; 46(5):1343-9. PubMed ID: 17260963
[TBL] [Abstract][Full Text] [Related]
3. Probing the function, conformational plasticity, and dimer-dimer contacts of the GluR2 ligand-binding core: studies of 5-substituted willardiines and GluR2 S1S2 in the crystal.
Jin R; Gouaux E
Biochemistry; 2003 May; 42(18):5201-13. PubMed ID: 12731861
[TBL] [Abstract][Full Text] [Related]
4. Role of conformational dynamics in α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor partial agonism.
Ramaswamy S; Cooper D; Poddar N; MacLean DM; Rambhadran A; Taylor JN; Uhm H; Landes CF; Jayaraman V
J Biol Chem; 2012 Dec; 287(52):43557-64. PubMed ID: 23115239
[TBL] [Abstract][Full Text] [Related]
5. Stereochemistry of glutamate receptor agonist efficacy: engineering a dual-specificity AMPA/kainate receptor.
Madden DR; Cheng Q; Thiran S; Rajan S; Rigo F; Keinänen K; Reinelt S; Zimmermann H; Jayaraman V
Biochemistry; 2004 Dec; 43(50):15838-44. PubMed ID: 15595838
[TBL] [Abstract][Full Text] [Related]
6. Chemistry and conformation of the ligand-binding domain of GluR2 subtype of glutamate receptors.
Cheng Q; Jayaraman V
J Biol Chem; 2004 Jun; 279(25):26346-50. PubMed ID: 15100219
[TBL] [Abstract][Full Text] [Related]
7. Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons.
Wong LA; Mayer ML; Jane DE; Watkins JC
J Neurosci; 1994 Jun; 14(6):3881-97. PubMed ID: 7515954
[TBL] [Abstract][Full Text] [Related]
8. NMR spectroscopy of the ligand-binding core of ionotropic glutamate receptor 2 bound to 5-substituted willardiine partial agonists.
Fenwick MK; Oswald RE
J Mol Biol; 2008 May; 378(3):673-85. PubMed ID: 18387631
[TBL] [Abstract][Full Text] [Related]
9. Allosteric mechanism in AMPA receptors: a FRET-based investigation of conformational changes.
Ramanoudjame G; Du M; Mankiewicz KA; Jayaraman V
Proc Natl Acad Sci U S A; 2006 Jul; 103(27):10473-10478. PubMed ID: 16793923
[TBL] [Abstract][Full Text] [Related]
10. Glutamate receptors as seen by light: spectroscopic studies of structure-function relationships.
Mankiewicz KA; Jayaraman V
Braz J Med Biol Res; 2007 Nov; 40(11):1419-27. PubMed ID: 17934637
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for partial agonist action at ionotropic glutamate receptors.
Jin R; Banke TG; Mayer ML; Traynelis SF; Gouaux E
Nat Neurosci; 2003 Aug; 6(8):803-10. PubMed ID: 12872125
[TBL] [Abstract][Full Text] [Related]
12. Purification and crystallization of a non-GluR2 AMPA-receptor ligand-binding domain: a case of cryo-incompatibility addressed by room-temperature data collection.
Gill A; Madden DR
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2008 Sep; 64(Pt 9):831-5. PubMed ID: 18765917
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between agonists and antagonists by the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid-selective glutamate receptor. A mutation analysis of the ligand-binding domain of GluR-D subunit.
Lampinen M; Settimo L; Pentikainen OT; Jouppila A; Mottershead DG; Johnson MS; Keinanen K
J Biol Chem; 2002 Nov; 277(44):41940-7. PubMed ID: 12167621
[TBL] [Abstract][Full Text] [Related]
14. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine.
Patneau DK; Mayer ML; Jane DE; Watkins JC
J Neurosci; 1992 Feb; 12(2):595-606. PubMed ID: 1371315
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of partial agonism at the GluR2 AMPA receptor: Measurements of lobe orientation in solution.
Maltsev AS; Ahmed AH; Fenwick MK; Jane DE; Oswald RE
Biochemistry; 2008 Oct; 47(40):10600-10. PubMed ID: 18795801
[TBL] [Abstract][Full Text] [Related]
16. Microsecond-to-millisecond conformational dynamics demarcate the GluR2 glutamate receptor bound to agonists glutamate, quisqualate, and AMPA.
Valentine ER; Palmer AG
Biochemistry; 2005 Mar; 44(9):3410-7. PubMed ID: 15736951
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes at the agonist binding domain of the N-methyl-D-aspartic acid receptor.
Rambhadran A; Gonzalez J; Jayaraman V
J Biol Chem; 2011 May; 286(19):16953-7. PubMed ID: 21454656
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate.
Jin R; Horning M; Mayer ML; Gouaux E
Biochemistry; 2002 Dec; 41(52):15635-43. PubMed ID: 12501192
[TBL] [Abstract][Full Text] [Related]
19. Molecular pharmacology of the AMPA agonist, (S)-2-amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid [(S)-APPA] and the AMPA antagonist, (R)-APPA.
Ebert B; Madsen U; Lund TM; Lenz SM; Krogsgaard-Larsen P
Neurochem Int; 1994 Jun; 24(6):507-15. PubMed ID: 7526921
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
Armstrong N; Gouaux E
Neuron; 2000 Oct; 28(1):165-81. PubMed ID: 11086992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
